Azurity Pharmaceuticals, Inc., based in Woburn, MA, specializes in the development and manufacturing of pharmaceutical compositions. The company focuses on innovative formulations of established medications, including clonidine, amlodipine, zonisamide, and nilotinib, among others. Azurity is dedicated to addressing unmet medical needs through its expertise in drug delivery and formulation science, particularly in areas such as colon cleansing and gastrointestinal health, enhancing patient outcomes with tailored therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

51 Patents

#9 in Woburn, MA

#391 in Massachusetts

#6,893 in US

#13,788 in the World

Woburn, MA, United States of America

Azurity Pharmaceuticals, Inc.

Forward Citations = 70

49 inventors:

Gerold L Mosher (14 out of 66 patents)

Zeus Pendon (10 out of 11 patents)

Scott Brauer (9 out of 14 patents)

4. Peter Mione (7 out of 12 patents)

5. Anisa Gandhi (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Azurity Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/azurity-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]